What Happened?
, -based ProKidney Appointed Nikhil Pereira-Kamath as Chief Business Officer
Date of management change: November 30, 2023
, -based ProKidney Appointed Nikhil Pereira-Kamath as Chief Business Officer
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Nikhil Pereira-Kamath is Chief Business Officer at ProKidney. Previously, Nikhil held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Crobsy Troy, Stalcup Marianne, Brodie Jodi, Hudson Heidi, Sadolin Brynna, Young Kevin, Gochenour Bryan, Janiak Stacy, Bohm Crystal, Malone Walt, Sinclair Connie
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.